These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26799260)

  • 21. Clinical outcomes of stereotactic body radiation therapy for small hepatocellular carcinoma.
    Park S; Jung J; Cho B; Kim SY; Yun SC; Lim YS; Lee HC; Park J; Park JH; Kim JH; Yoon SM
    J Gastroenterol Hepatol; 2020 Nov; 35(11):1953-1959. PubMed ID: 32052884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biologically effective dose (BED) of stereotactic body radiation therapy (SBRT) was an important factor of therapeutic efficacy in patients with hepatocellular carcinoma (≤5 cm).
    Sun J; Zhang T; Wang J; Li W; Zhang A; He W; Zhang D; Li D; Ding J; Duan X
    BMC Cancer; 2019 Aug; 19(1):846. PubMed ID: 31455251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local effect of stereotactic body radiotherapy for primary and metastatic liver tumors in 130 Japanese patients.
    Yamashita H; Onishi H; Matsumoto Y; Murakami N; Matsuo Y; Nomiya T; Nakagawa K;
    Radiat Oncol; 2014 May; 9():112. PubMed ID: 24886477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Stereotactic Body Radiation Therapy Combined With or Without Transcatheter Arterial Chemoembolization for Patients With Small Hepatocellular Carcinoma Ineligible for Resection or Ablation Therapies.
    Kimura T; Aikata H; Doi Y; Imano N; Takeuchi Y; Takahashi I; Nishibuchi I; Katsuta T; Kenjo M; Murakami Y; Awai K; Chayama K; Nagata Y
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818783450. PubMed ID: 29963972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma.
    Cárdenes HR; Price TR; Perkins SM; Maluccio M; Kwo P; Breen TE; Henderson MA; Schefter TE; Tudor K; Deluca J; Johnstone PA
    Clin Transl Oncol; 2010 Mar; 12(3):218-25. PubMed ID: 20231127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeated stereotactic ablative radiotherapy using CyberKnife for patients with hepatocellular carcinoma.
    Lo CH; Huang WY; Lin KT; Lin MJ; Lin TP; Jen YM
    J Gastroenterol Hepatol; 2014 Nov; 29(11):1919-25. PubMed ID: 25041220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison Between Child-Turcotte-Pugh and Albumin-Bilirubin Scores in Assessing the Prognosis of Hepatocellular Carcinoma After Stereotactic Ablative Radiation Therapy.
    Lo CH; Liu MY; Lee MS; Yang JF; Jen YM; Lin CS; Chao HL; Shen PC; Huang WY
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):145-152. PubMed ID: 28816140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer.
    Kwon JH; Bae SH; Kim JY; Choi BO; Jang HS; Jang JW; Choi JY; Yoon SK; Chung KW
    BMC Cancer; 2010 Sep; 10():475. PubMed ID: 20813065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-Term Survival Analysis of Stereotactic Ablative Radiotherapy Versus Liver Resection for Small Hepatocellular Carcinoma.
    Su TS; Liang P; Liang J; Lu HZ; Jiang HY; Cheng T; Huang Y; Tang Y; Deng X
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):639-646. PubMed ID: 28581406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic body radiotherapy versus hepatic resection for hepatocellular carcinoma (≤ 5 cm): a propensity score analysis.
    Sun J; Wang Q; Hong ZX; Li WG; He WP; Zhang T; Zhang AM; Fan YZ; Sun YZ; Zheng L; Duan XZ
    Hepatol Int; 2020 Sep; 14(5):788-797. PubMed ID: 32886334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Local control by salvage stereotactic body radiotherapy for recurrent/residual hepatocellular carcinoma after other local therapies.
    Kibe Y; Takeda A; Tsurugai Y; Eriguchi T
    Acta Oncol; 2020 Aug; 59(8):888-894. PubMed ID: 32216593
    [No Abstract]   [Full Text] [Related]  

  • 32. Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study.
    Su TS; Liu QH; Zhu XF; Liang P; Liang SX; Lai L; Zhou Y; Huang Y; Cheng T; Li LQ
    Radiat Oncol; 2021 Apr; 16(1):79. PubMed ID: 33882972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereotactic body radiation therapy for early hepatocellular carcinoma: a retrospective analysis of the South Australian experience.
    Wigg AJ; Narayana SK; Le H; Iankov I; Chinnaratha MA; Tse E; Chen JW; Gowda R
    ANZ J Surg; 2019 Sep; 89(9):1138-1143. PubMed ID: 30983104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereotactic body radiation therapy using a respiratory-gated volumetric-modulated arc therapy technique for small hepatocellular carcinoma.
    Jeong Y; Jung J; Cho B; Kwak J; Jeong C; Kim JH; Park JH; Kim SY; Shim JH; Kim KM; Lim YS; Lee HC; Yoon SM
    BMC Cancer; 2018 Apr; 18(1):416. PubMed ID: 29653562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies.
    Goodman KA; Wiegner EA; Maturen KE; Zhang Z; Mo Q; Yang G; Gibbs IC; Fisher GA; Koong AC
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):486-93. PubMed ID: 20350791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I dose escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma.
    Kim JW; Seong J; Lee IJ; Woo JY; Han KH
    Oncotarget; 2016 Jun; 7(26):40756-40766. PubMed ID: 27213593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Individualized Adaptive Radiation Therapy Allows for Safe Treatment of Hepatocellular Carcinoma in Patients With Child-Turcotte-Pugh B Liver Disease.
    Jackson WC; Tang M; Maurino C; Mendiratta-Lala M; Parikh ND; Matuszak MM; Dow JS; Cao Y; Mayo CS; Ten Haken RK; Schipper MJ; Cuneo KC; Owen D; Lawrence TS
    Int J Radiat Oncol Biol Phys; 2021 Jan; 109(1):212-219. PubMed ID: 32853708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Multi-Institutional Retrospective Study of Repeated Stereotactic Body Radiation Therapy for Intrahepatic Recurrent Hepatocellular Carcinoma.
    Kimura T; Takeda A; Tsurugai Y; Kawano R; Doi Y; Oku Y; Hioki K; Miura H; Nagata Y
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1265-1275. PubMed ID: 32712256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereotactic body radiotherapy in hepatocellular carcinoma: patient selection and predictors of outcome and toxicity.
    Loi M; Comito T; Franzese C; Dominici L; Lo Faro L; Clerici E; Franceschini D; Mancosu P; Reggiori G; Gallo P; Badalamenti M; Scorsetti M
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):927-936. PubMed ID: 32945972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: clinical and dose-volumetric parameters.
    Jung J; Yoon SM; Kim SY; Cho B; Park JH; Kim SS; Song SY; Lee SW; Ahn SD; Choi EK; Kim JH
    Radiat Oncol; 2013 Oct; 8():249. PubMed ID: 24160910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.